AMGEN INC — Director's Dealing 2022

Jan 12, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vigil Neuroscience, Inc. (VIGL)
CIK: 0001827087
Period of Report: 2022-01-11

Reporting Person: AMGEN INC (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-01-11	Common Stock	C	3206281	—	Acquired	3206281	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-01-11	Series A Preferred Stock	$	C	3206281	Disposed		Common Stock (3206281)	Direct

Footnotes

F1: These shares of Series A Preferred Stock were converted into shares of the Issuer's common stock on a one-for-2.7732 basis upon the completion of the Issuer's initial public offering